The R&D World Index (RDWI) for the week ending May 27, 2022, closed at 4,731.09 for the 25 companies in the RDWI. The Index was up 4.01% (or 182.29 basis points) from the week ending May 20, 2022. Twenty-two of the 25 RDWI members gained value from 0.52% (Honda Motors) to 8.95% (General Motors). Three…
Companies barreling ahead with R&D Plans, in this week’s R&D Power Index
Global R&D firms focusing on U.S., in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending May 13, 2022, closed at 4,717.95 for the 25 companies in the RDWI. The Index was down -1.11% (or -52.96 basis points) from the week ending May 7, 2022. Nine of the 25 RDWI members gained value from 0.26% (Alphabet/Google) to 1.23% (Sanofi SA). Sixteen of…
FDA limits J&J COVID-19 Vaccine, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending May 6, 2022, closed at 4,770.91 for the 25 companies in the RDWI. The Index was up 0.68% (or 32.40 basis points) from the week ending April 29, 2022. Twelve of the 25 RDWI members gained value from 0.35% (Ford Motor) to 4.41% (General Motors). Thirteen…
U.S. economy falls, but corporate R&D continues, in this week’s R&D power index
The R&D World Index (RDWI) for the week ending April 29, 2022, closed at 4,738.51 for the 25 companies in the RDWI. The Index was down -2.01% (or -97.21 basis points) from the week ending April 22, 2022. Nine of the 25 RDWI members gained value from 0.82% (Astra Zeneca PLC) to 12.26% (Alibaba). Sixteen…
War and inflation cut global R&D spend, in this week’s R&D Power Index
Inflation hits 40-year high, but relief seen, in this week’s R&D power index
Inflation is likely here to stay, in this week’s R&D power index
New R&D projects focusing on the U.S., in this week’s R&D power index
The R&D World Index (RDWI) for the week ending April 1, 2022, closed at 5,401.20 for the 25 companies in the RDWI. The Index was down -0.28% (or 15.28 basis points) from the week ending March 25, 2022. Sixteen of the 25 RDWI members gained value from 0.26% (Daimler AG) to 4.73% (Volkswagen AG). Nine…
Inflation cures sitting on knife’s edge, in this week’s R&D power index
Global inflation and war threaten R&D plans, in this week’s R&D power index
Inflation will affect 2023 R&D, in this week’s R&D power index
Hydrogen and coal are powering the future, in this week’s R&D power index
R&D collaborations looking to build expertise, in this week’s R&D power index
The R&D World Index (RDWI) for the week ending February 18, 2022, closed at 5,075.11 for the 25 companies in the RDWI. The Index was down -2.18% (or 113.00 basis points) from the week ending February 11, 2022. The stock of nine RDWI members gained value from 0.96% (Novartis) to 6.14% (Cisco). The stock of…
Inflation will be R&D game changer in 2022, in this week’s R&D power index
The R&D World Index (RDWI) for the week ending February 11, 2022, closed at 5,188.11 for the 25 companies in the RDWI. The Index was down -4.28% (or 231.98 basis points) from the week ending February 4, 2022. The stock of eight RDWI members gained value from 0.02% (Alibaba) to 5.34% (Daimler AG). The stock…
Intel wants to regain “chipzilla” status, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending February 4, 2022, closed at 5,420.09 for the 25 companies in the RDWI. The Index was up 2.64% (or 139.41 basis points) from the week ending January 28, 2022. The stock of 13 RDWI members gained value from 0.12% (Bristol-Myers Squibb) to 7.46% (Alphabet/Google). The stock…
Greater than expected growth in fourth quarter, in this week’s R&D power index
The R&D World Index (RDWI) for the week ending January 28, 2022, closed at 5,280.68 for the 25 companies in the RDWI. The Index was up 1.39% (or 72.41 basis points) from the week ending January 21, 2022. The stock of 12 RDWI members gained value from 0.34% (AstraZeneca) to 4.88% (Apple Computer). The stock…
Rising inflation rates undermine economic growth, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending January 21, 2022, closed at 5,208.27 for the 25 companies in the RDWI. The Index was down -5.66% (or 312.43 basis points) from the week ending January 14, 2022. The stock of only one RDWI member gained value at 0.42% (AstraZeneca). The stock of 24 RDWI…
Sony and Foxconn developing EVs, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending January 7, 2022, closed at 5,472.25 for the 25 companies in the RDWI. The Index was down -2.79% (or -157.25 basis points) from the week ending December 31, 2021. The stock of 16 RDWI members gained value from 0.17% (Roche Holdings AG) to 17.67% (Ford Motor).…
EVs becoming more collaborative, in this week’s R&D power Index
The R&D World Index (RDWI) for the week ending December 31, 2021, closed at 5,629.50 for the 25 companies in the RDWI. The Index was down -0.39% (or -22.32 basis points) from the week ending December 24, 2021. The stock of 21 RDWI members gained value from 0.11% (Alibaba) to 3.02% (General Motors). The stock…
Most new COVID-19 U.S. cases are Omicron variants, in this week’s R&D Power Index
The R&D World Index (RDWI) for the week ending December 24, 2021, closed at 5,651.82 for the 25 companies in the RDWI. The Index was up 2.42% (or 133.72 basis points) from the week ending December 17, 2021. The stock of 20 RDWI members gained value from 0.01% (Johnson & Johnson) to 3.66% (Alphabet/Google). The…
Positive results for Pfizer’s COVID-19 pill, this week in the R&D Power Index
The R&D World Index (RDWI) for the week ending December 17, 2021, closed at 5,518.10 for the 25 companies in the RDWI. The Index was down -2.09% (or -117.84 basis points) from the week ending December 10, 2021. The stock of 14 RDWI members gained value from 0.06% (Intel) to 12.69% (Pfizer). The stock of…
Samsung reorganizes and EPA relents on regs, this week in the R&D Power Index
The R&D World Index (RDWI) for the week ending December 10, 2021, closed at 5,635.94 for the 25 companies in the RDWI. The Index was up 4.19% (or 226.57 basis points) from the week ending December 3, 2021. The stock of 19 RDWI members gained value from 0.07% (Bristol-Myers Squibb) to 16.31% (Oracle). The stock…
Biopharms scambling to find Omicron variant drug, this week in the R&D Power Index
The R&D World Index (RDWI) for the week ending December 3, 2021, closed at 5,409.37 for the 25 companies in the RDWI. The Index was down -1.28% (or -70.04 basis points) from the week ending November 26, 2021. The stock of 11 RDWI members gained value from 0.11% (Johnson & Johnson) to 3.21% (Apple). The…
Omicron variant to take weeks to evaluate, this week in the R&D Power Index
The R&D World Index (RDWI) for the week ending November 26, 2021, closed at 5,479.41 for the 25 companies in the RDWI. The Index was down -3.48% (or -197.51 basis points) from the week ending November 19, 2021. The stock of four RDWI members gained value from 0.23% (AbbVie) to 6.30% (Pfizer). The stock of…